AS

Arjun Singh

Active Director Director DIN 08540370
DIN 08540370 First appointment Aug 2019 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2019
Shareholding value •••• Premium profile

About Arjun Singh

Data last updated:

Arjun Singh is a Director at Sindur Pharma Private Limited (since 2019). The company operates in Business Services. Sindur Pharma Private Limited reported revenue of ₹4.5 Lakh (FY 2024).

DIN 08540370
Primary Designation Director
Industry Business Services
First Appointment 19 Aug 2019
Oldest Company Age 7 yrs
Largest company Sindur Pharma Private Limited · ₹4.5 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sindur Pharma Private Limited U74999MP2019PTC049363
Director19 Aug 20192019₹4.5 Lakh (FY 2024)Active

Board colleagues of Arjun Singh

NameDINCompanyDesignation
Mukesh Lodhi08738666Sindur Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sindur Pharma Private Limited
Premium access

Shareholding and investment profile for Arjun Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arjun Singh

Arjun Singh currently holds 1 directorship: Sindur Pharma Private Limited (Director, since 19 Aug 2019, revenue ₹4.5 Lakh (FY 2024)).

Arjun Singh was first appointed on 19 Aug 2019 as Director at Sindur Pharma Private Limited.

The current boards of Arjun Singh's companies include Mukesh Lodhi (Sindur Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available